Does Statistical Decrease of Mortality Rates by a Factor of about 2.5 Suggest Revolutional Progress in Melanoma Treatment from Year 2009 to 2017?

Ernst-Peter Rührnschopf*

Imaging & Therapy Division, Healthcare Sector, Siemens Medical Systems, Erlangen, Germany

^*Correspondance to: Ernst-Peter Rührnschopf 

 PDF  Full Text Short Communication | Open Access

Abstract:

Comparison of mortality rates (for 5 years and 10 years, resp.), derived from the leading AJCC melanoma staging system references from 2009 and 2017, are showing an astounding decrease by a factor of about 2.5 (± 0.1) for different cutaneous melanoma stages, e.g. IIB, IIC, and IIIB, whereas the respective comparison between the former references from 2001 and 2009 amounts only to a factor of about 1.1 (± 0.05). The dramatic improvement in the short time from 2009 to 2017 suggests a revolutional progress in melanoma treatment, perhaps unsurpassed in the history of cancer.

Keywords:

Cite the Article:

Rührnschopf E-P. Does Statistical Decrease of Mortality Rates by a Factor of about 2.5 Suggest Revolutional Progress in Melanoma Treatment from Year 2009 to 2017?. Clin Oncol. 2019; 4: 1647 .